Cite

HARVARD Citation

    Shefner, J. et al. (2019). A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and frontotemporal degeneration. 20 (7), pp. 584-594. [Online]. 
  
Back to record